IKAP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aurinia Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 13.16 EUR -2.34% Market Closed

Market Cap: €1.9B

A	Aurinia Pharmaceuticals Inc F:IKAP	CA
	Compania de Minas Buenaventura SAA F:MBU	PE
A	AbraSilver Resource Corp F:1AH	CA
	Bradespar SA BOVESPA:BRAP4	BR
	Adyen NV AEX:ADYEN	NL
	Century Lithium Corp F:C1Z	CA
W	Welsbach Technology Metals Acquisition Corp NASDAQ:WTMA	US
E	Experian PLC OTC:EXPGF	IE
C	Credit Agricole SA DUS:XCA	FR
E	E ON SE PSE:EOAN	DE

Profitability Summary

Aurinia Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

90%

Declining Gross Margin

96% > 90%

Exceptional Operating Margin

42%

Negative 3Y Average Operating Margin

-6%

Operating Margin is Increasing

-52% > 42%

Exceptional Net Margin

100%

Low 3Y Average Net Margin

Net Margin is Increasing

-45% > 100%

Exceptional Free Cash Flow Margin

56%

Strong 3Y Average Free Cash Flow Margin

13%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.